Cargando…

Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer

Breast cancer patients treated with tamoxifen may experience recurrence due to endocrine resistance, which highlights the need for additional predictive and prognostic biomarkers. The glyco-phosphoprotein osteopontin (OPN), encoded by the SPP1 gene, has previously shown to be associated with poor pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Göthlin Eremo, Anna, Lagergren, Kajsa, Othman, Lana, Montgomery, Scott, Andersson, Göran, Tina, Elisabet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989629/ https://www.ncbi.nlm.nih.gov/pubmed/31996744 http://dx.doi.org/10.1038/s41598-020-58323-w

Ejemplares similares

SLC7A5 is linked to increased expression of genes related to proliferation and hypoxia in estrogen-receptor-positive breast cancer
por: Törnroos, Rasmus, et al.
Publicado: (2022)

Decreased expression of the mitochondrial solute carrier SLC25A43 in basal cell carcinoma compared with healthy skin
por: Prosén, Sara, et al.
Publicado: (2017)

Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma
por: Tina, E., et al.
Publicado: (2018)

The Role of Osteopontin (OPN/SPP1) Haplotypes in the Susceptibility to Crohn's Disease
por: Glas, Jürgen, et al.
Publicado: (2011)

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients
por: Klebaner, Daniella, et al.
Publicado: (2017)

Osteopontin splice variants are differential predictors of breast cancer treatment responses
por: Zduniak, Krzysztof, et al.
Publicado: (2016)

Platelet proteome and function in X−linked thrombocytopenia with thalassemia and in silico comparisons with gray platelet syndrome
por: Bergemalm, Daniel, et al.
Publicado: (2020)

SPP1/osteopontin: a driver of fibrosis and inflammation in degenerative ascending aortic aneurysm?
por: Freiholtz, David, et al.
Publicado: (2023)

Osteopontin (SPP1) expression on gallstone formation in rabbits fed with a lithogenic diet
por: Abdal, Tareek Abdulqadir, et al.
Publicado: (2023)

Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen
por: Prat, A., et al.
Publicado: (2012)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
por: Elias, D., et al.
Publicado: (2019)

Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer
por: Montagna, Emilia, et al.
Publicado: (2021)

K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene
por: Hachisuga, T, et al.
Publicado: (2005)

Danger signal extracellular calcium initiates differentiation of monocytes into SPP1/osteopontin-producing macrophages
por: Murthy, Supriya, et al.
Publicado: (2022)

Tamoxifen to treat male pubertal gynaecomastia
por: Zehetner, Anthony
Publicado: (2015)

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
por: Egeland, Nina Gran, et al.
Publicado: (2020)

Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen
por: Baek, Soo Yeon, et al.
Publicado: (2019)

Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients
por: Ximenez, João Paulo Bianchi, et al.
Publicado: (2019)

Effects of cyclin D(1 )gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study
por: Lundgren, Katja, et al.
Publicado: (2012)

Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
por: Polat, Bülent, et al.
Publicado: (2022)

Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
por: Lin, Jules, et al.
Publicado: (2015)

Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk
por: Pistilli, Barbara, et al.
Publicado: (2020)

Osteopontin and Fatty Acid Binding Protein in Ifosfamide-treated Rats
por: Dobrek, Łukasz, et al.
Publicado: (2019)

The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
por: Albertsson, Anna-Maj, et al.
Publicado: (2014)

The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis
por: Lavi, Hadas, et al.
Publicado: (2017)

Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients
por: AlZaabi, Adhari, et al.
Publicado: (2021)

Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden
por: Chandanos, E, et al.
Publicado: (2006)

Osteopontin as an early predictor of atherosclerosis in attack-free Familial Mediterranean fever patients
por: Baspinar, Osman, et al.
Publicado: (2023)

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients
por: Egeland, Nina G., et al.
Publicado: (2015)

Expression of CARD8 in human atherosclerosis and its regulation of inflammatory proteins in human endothelial cells
por: Paramel, Geena V., et al.
Publicado: (2020)

Author Correction: Expression of CARD8 in human atherosclerosis and its regulation of inflammatory proteins in human endothelial cells
por: Paramel, Geena V., et al.
Publicado: (2021)

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.
por: Foekens, J. A., et al.
Publicado: (1994)

4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015)

Expression of osteopontin and osteonectin in breast cancer.
por: Kim, Y. W., et al.
Publicado: (1998)

Tamoxifen Therapy for Recurrent Mucosal Bleeding in Hereditary Hemorrhagic Telangiectasia
por: Yung, Stephanie, et al.
Publicado: (2021)

Osteopontin and oral carcinogenesis
por: Kapoor, Shailendra
Publicado: (2008)

The Effect of Osteopontin on Microglia
por: Yu, Huan, et al.
Publicado: (2017)

Osteopontin in Cardiovascular Diseases
por: Shirakawa, Kohsuke, et al.
Publicado: (2021)

Osteopontin in Pulmonary Hypertension
por: Mamazhakypov, Argen, et al.
Publicado: (2023)

Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity
por: Filiberti, Adrian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j941if0q0b7e3ijj1ojpb8qdes